Theriva Biologics, Inc. (TOVX) — research page
US · us-cm-kg/NYSE/TOVX · as of 2026-11-08
Identity and listing
Theriva Biologics, Inc. is listed on the NYSE under the ticker TOVX, with ISIN US87164U5083 and LEI 529900RVC1I52VWB3G55. Its security type is Corporate and its sector is 2834 Pharmaceutical Preparations. Its jurisdiction is United States — Nevada, and its segment is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Theriva Biologics, Inc. | source · 2026-11-08 |
| exchange | NYSE | source · 2026-11-08 |
| ticker | TOVX | source · 2026-11-08 |
| ISIN | US87164U5083 | source · 2026-10-13 |
| LEI | 529900RVC1I52VWB3G55 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Nevada | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 44 filings on 34 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 8 days, against an exchange median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-11-02, a corporate news filing, 6 days before the record date. The exchange median latency is 4.0 days and the sector median latency is 4.0 days. The exchange median count of filings is 64.0 and the sector median is 63.0.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 44 | 8 | 6 |
| exchange median: NYSE (3256 issuers) | 64 | 6 | 4 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-02 | corporate_news | 8-K | 8-K — FORM 8-K (items 1.01,2.01,7.01,9.01) |
| 2026-10-20 | agm_egm | DEF 14A | DEF 14A — DEF 14A |
| 2026-10-09 | agm_egm | PRE 14A | PRE 14A — PRE 14A |
| 2026-08-24 | regulatory_filing | S-8 | S-8 — FORM S-8 |
| 2026-08-11 | results | 10-Q | 10-Q — 10-Q |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is BDO USA, P.C, located in Raleigh, North Carolina. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names 2 research houses: A.G.P. / Alliance Global Partners and Maxim Group.
| research house | analyst | source · read date |
|---|---|---|
| A.G.P. / Alliance Global Partners | James Molloy | issuer page · 2026-11-11 |
| Maxim Group | Jason McCarthy, Ph.D | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0000894158.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NYSE/TOVX (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/894158/000110465926026767/tmb-20251231x10k.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://therivabio.com/investors/stock-information/ (coverage)
- 10.10
- https://mcp.us-cm-kg.ai/record/NYSE/TOVX (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US87164U5083"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:41d66ca557b1fb18.